Biblio
Export 1190 results:
Author Title [ Type] Year Filters: First Letter Of Last Name is D [Clear All Filters]
“Effects of Healthy Aging and Mild Cognitive Impairment on a Real-Life Decision-Making Task.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1077-1087, 2017.
, “Effects of Probiotic Supplementation on Short Chain Fatty Acids in the AppNL-G-F Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 76, no. 3, pp. 1083-1102, 2020.
, “Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1325-1334, 2017.
, “Effects of Striatal Amyloidosis on the Dopaminergic System and Behavior: A Comparative Study in Male and Female 5XFAD Mice.”, J Alzheimers Dis, vol. 94, no. 4, pp. 1361-1375, 2023.
, “Efficacy and Safety of Crocus sativus L. in Patients with Mild Cognitive Impairment: One Year Single-Blind Randomized, with Parallel Groups, Clinical Trial.”, J Alzheimers Dis, vol. 54, no. 1, pp. 129-33, 2016.
, “Efficacy and Safety of Donepezil in Chinese Patients with Severe Alzheimer's Disease: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1495-1504, 2017.
, “Efficacy of Souvenaid® Combined with Acetylcholinesterase Inhibitors in the Treatment of Mild Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1459-1469, 2023.
, “Efficacy of Souvenaid® Combined with Acetylcholinesterase Inhibitors in the Treatment of Mild Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1459-1469, 2023.
, “Elevation of Plasma Amyloid-β Level is More Significant in Early Stage of Cognitive Impairment: A Population-Based Cross-Sectional Study.”, J Alzheimers Dis, vol. 64, no. 1, pp. 61-69, 2018.
, “Elevation of Plasma Amyloid-β Level is More Significant in Early Stage of Cognitive Impairment: A Population-Based Cross-Sectional Study.”, J Alzheimers Dis, vol. 64, no. 1, pp. 61-69, 2018.
, “The Emergence of a New Conceptual Framework for Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1059-1066, 2018.
, “Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline.”, J Alzheimers Dis, vol. 50, no. 1, pp. 271-82, 2016.
, “Endocytosis and Transcytosis of Amyloid-β Peptides by Astrocytes: A Possible Mechanism for Amyloid-β Clearance in Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1109-1124, 2018.
, “Entorhinal Perfusion Predicts Future Memory Decline, Neurodegeneration, and White Matter Hyperintensity Progression in Older Adults.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1711-1725, 2021.
, “Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution.”, J Alzheimers Dis, vol. 78, no. 2, pp. 479-503, 2020.
, “An epigenetic blockade of cognitive functions in the neurodegenerating brain.”, Nature, vol. 483, no. 7388, pp. 222-6, 2012.
, “Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study.”, J Alzheimers Dis, vol. 74, no. 3, pp. 865-874, 2020.
, “Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study.”, J Alzheimers Dis, vol. 74, no. 3, pp. 865-874, 2020.
, “Epileptic Prodromal Alzheimer's Disease, a Retrospective Study of 13 New Cases: Expanding the Spectrum of Alzheimer's Disease to an Epileptic Variant?”, J Alzheimers Dis, vol. 52, no. 3, pp. 1125-33, 2016.
, “Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1143-1162, 2018.
, “Ethical Issues in the Treatment of Late-Stage Alzheimer's Disease.”, J Alzheimers Dis, vol. 68, no. 4, pp. 1311-1316, 2019.
, “The Ethyl Acetate Extract of Leaves of Ugni molinae Turcz. Improves Neuropathological Hallmarks of Alzheimer's Disease in Female APPswe/PS1dE9 Mice Fed with a High Fat Diet.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1175-1191, 2018.
, “Evaluating Peripersonal Space through the Functional Transcranial Doppler: Are We Paving the Way for Early Detecting Mild Cognitive Impairment to Dementia Conversion?”, J Alzheimers Dis, vol. 62, no. 1, pp. 133-143, 2018.
, “Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 3, pp. 921-32, 2016.
, “Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 3, pp. 921-32, 2016.
,